Severe COVID-19 Outcomes Rare After Primary Vaccination
MONDAY, Jan. 10, 2022 (HealthDay News) — Severe COVID-19 outcomes are rare after primary vaccination, but those who are 65 years or older, are immunosuppressed, or have underlying conditions may be at increased risk, according to research published …
Learn MoreInterventions to Promote Physical Activity May Benefit Asthma Patients
MONDAY, Jan. 10, 2022 (HealthDay News) — Interventions that promote physical activity have significant benefits in terms of increasing physical activity, decreasing sedentary time, and improving quality of life in patients with asthma, according to a…
Learn MoreResponsive Neurostimulation Tolerated in Pediatric Epilepsy
MONDAY, Jan. 10, 2022 (HealthDay News) — Responsive neurostimulation (RNS; NeuroPace) is tolerated and may be effective in carefully selected pediatric epilepsy patients, according to a study published in the December issue of Neurosurgery.
Yasunori Nagahama, M.D., from the University of California in Los Angeles, and colleagues examined the real-world efficacy and safety of RNS in childhood-onset drug-resistant epilepsy at five pediatric centers. The reductions in disabling seizures and complications were examined for 35 patients, including a 3-year-old (17 patients were younger than 18 years at the time of RNS implantation). Four of the patients had concurrent resection.
The researchers identified three complications in young adults that required additional surgical intervention (two infections and one lead fracture). Children had no complications. Of the 32 patients with continued therapy, 6 percent achieved seizure freedom, and 13, 41, and 25 percent achieved ≥90 percent reduction, ≥50 percent reduction, and
“The findings suggest that responsive neurostimulation is an effective off-label surgical treatment of drug-resistant epilepsy in carefully selected pediatric patients,” Nagahama said in a statement. “However, more research on long-term efficacy and safety is needed to determine which patients will benefit most.”
Abstract/Full Text (subscription or payment may be required)
Learn MorePhysician’s Briefing Weekly Coronavirus Roundup
Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of Jan. 3 to 7, 2022. This roundup includes the latest research news from journal studies and other trusted sourc…
Learn MorePhysician’s Briefing Weekly Coronavirus Roundup
Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of Jan. 3 to 7, 2022. This roundup includes the latest research news from journal studies and other trusted sourc…
Learn MoreWhite House Finalizes Plan to Send Americans Free COVID-19 Rapid Tests
FRIDAY, Jan. 7, 2022 (HealthDay News) — The final touches are being put on the White House’s plan to deliver 500 million free COVID-19 rapid at-home test kits to households across America.The administration will launch a website where people can requ…
Learn MoreFDA Shortens Time to Booster After Moderna Vaccine to Five Months
FRIDAY, Jan. 7, 2022 (HealthDay News) — Citing the rapid spread of the omicron variant and the need for protection against it, U.S. federal health officials are shortening the recommended time between the second dose of the Moderna vaccine and a boos…
Learn MoreModerna CEO Says Fourth COVID-19 Dose May Be Needed Next Fall
FRIDAY, Jan. 7, 2022 (HealthDay News) — A fourth COVID-19 vaccine may be needed for most people by next fall because of what will likely be waning immunity, Moderna CEO Stephane Bancel said Thursday.While the booster that millions of Americans receiv…
Learn MoreSupreme Court Hears Arguments on Biden’s Vaccine Mandate for Big Business
FRIDAY, Jan. 7, 2022 (HealthDay News) — The Supreme Court began to hear oral arguments on Friday as it weighs whether the Biden administration can enforce vaccine mandates for large companies. The justices are also hearing arguments on a separate vac…
Learn MoreHospitals Are Rationing COVID-19 Pills, Infusions as Cases Rise
FRIDAY, Jan. 7, 2022 (HealthDay News) — It is the ultimate irony: More COVID-19 treatments exist now than at any other time during the pandemic, but the skyrocketing number of cases from the surging omicron variant might mean they cannot be accessed …
Learn More